These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30862442)

  • 1. Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
    Vahidian F; Duijf PHG; Safarzadeh E; Derakhshani A; Baghbanzadeh A; Baradaran B
    Immunol Lett; 2019 Apr; 208():19-29. PubMed ID: 30862442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.
    Müller L; Tunger A; Plesca I; Wehner R; Temme A; Westphal D; Meier F; Bachmann M; Schmitz M
    Front Immunol; 2020; 11():140. PubMed ID: 32117287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutualistic Effects of the Myeloid-Derived Suppressor Cells and Cancer Stem Cells in the Tumor Microenvironment.
    Tanriover G; Aytac G
    Crit Rev Oncog; 2019; 24(1):61-67. PubMed ID: 31679221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteine Cathepsins in Tumor-Associated Immune Cells.
    Jakoš T; Pišlar A; Jewett A; Kos J
    Front Immunol; 2019; 10():2037. PubMed ID: 31555270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Innate Immunity on Cancer Cell Stemness.
    Pastò A; Consonni FM; Sica A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic gene modified cell based cancer vaccines.
    Kozłowska A; Mackiewicz J; Mackiewicz A
    Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do tumor stem cells actively escape from host immunosurveillance?
    Qi Y; Li RM; Kong FM; Li H; Yu JP; Ren XB
    Biochem Biophys Res Commun; 2012 Apr; 420(4):699-703. PubMed ID: 22465008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
    Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
    Front Immunol; 2018; 9():1288. PubMed ID: 29915603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages and cancer stem cells: a malevolent alliance.
    Allavena P; Digifico E; Belgiovine C
    Mol Med; 2021 Sep; 27(1):121. PubMed ID: 34583655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR at the Transmitting and Receiving Ends in Tumor Immunity.
    Guri Y; Nordmann TM; Roszik J
    Front Immunol; 2018; 9():578. PubMed ID: 29662490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid-derived suppressor cells and their role in pancreatic cancer.
    Pergamo M; Miller G
    Cancer Gene Ther; 2017 Mar; 24(3):100-105. PubMed ID: 27910857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
    Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
    Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cells and tumor escape from immune surveillance.
    Umansky V; Blattner C; Fleming V; Hu X; Gebhardt C; Altevogt P; Utikal J
    Semin Immunopathol; 2017 Apr; 39(3):295-305. PubMed ID: 27787613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy.
    Wennerberg E; Lundqvist A; Mao Y; Mougiakakos D
    Front Immunol; 2021; 12():718844. PubMed ID: 34276709
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic Targeting of Cancer Stem Cells.
    Zhang J; Li Q; Chang AE
    Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Untold Story of Granzymes in Oncoimmunology: Novel Opportunities with Old Acquaintances.
    Arias M; Martínez-Lostao L; Santiago L; Ferrandez A; Granville DJ; Pardo J
    Trends Cancer; 2017 Jun; 3(6):407-422. PubMed ID: 28718416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells and T regulatory cells in tumors: unraveling the dark side of the force.
    Hatziioannou A; Alissafi T; Verginis P
    J Leukoc Biol; 2017 Aug; 102(2):407-421. PubMed ID: 28360184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.